United Therapeutics Corp (FRA:UTH)
€ 245.3 4.6 (1.91%) Market Cap: 10.88 Bil Enterprise Value: 8.92 Bil PE Ratio: 12.50 PB Ratio: 2.19 GF Score: 89/100

United Therapeutics Corp at Cowen Health Care Conference (Virtual) Transcript

Mar 08, 2022 / 04:10PM GMT
Release Date Price: €157 (-1.26%)
Joseph John;Charles Thome
Cowen and Company, LLC, Research Division - VP of Healthcare

Everyone, good morning, and thank you for joining us on day 2 of Cowen's 42nd Annual Healthcare Conference. I'm Joe Thome, one of the senior biotech analyst here on the team at Cowen. And it is my pleasure to have with me today President and COO, Michael Benkowitz, of United Therapeutics. And I'm going to kick it over to Head of IR, Dewey Steadman, to read some forward-looking statements.

Dewey Steadman
United Therapeutics Corporation - Head of IR

Hi. Good morning. Today's remarks will likely include forward-looking statements. And we encourage you to see our most recent SEC filings, including Form 10-K and Forms 10-Q available on the SEC EDGAR website.

And with that, I'll turn it back over to you, Joe.

Questions & Answers

Joseph John;Charles Thome
Cowen and Company, LLC, Research Division - VP of Healthcare

Thanks, Dewey. Mike, so maybe to just kick things off, obviously,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot